Moxetumomab Pasudotox-tdfk Injection
(mo" e toom' oh mab) (pa soo' doe tox)
Moxetumomab pasudotox-tdfk injection may cause a serious or life-threatening reaction called capillary leak syndrome (a condition that causes excess fluid in the body, low blood pressure, and low levels of a protein [albumin] in the blood). If you experience any of the following symptoms, call your doctor immediately: swelling of the face, hands, feet, ankles, or lower legs; weight gain; shortness of breath; cough; fainting; dizziness or lightheadedness; or fast or irregular heartbeat.
Moxetumomab pasudotox-tdfk injection may cause hemolytic uremic syndrome (a potentially life-threatening condition that involves injury to red blood cells, causing anemia and kidney problems). Tell your doctor if you have or have ever had kidney disease. If you experience any of the following symptoms, tell your doctor immediately: red or bloody stools or diarrhea; decreased urination; blood in urine; changes in mood or behavior; seizures; confusion; shortness of breath; swelling of the face, arms, hands, feet, ankles, or lower legs; unusual bleeding or bruising; stomach pain; vomiting; fever; pale skin; or unusual tiredness or weakness.
Keep all appointments with your doctor and the laboratory. Your doctor may order certain tests before, during, and after your treatment to check your body's response to moxetumomab pasudotox-tdfk injection.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with moxetumomab pasudotox-tdfk injection and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.
WHY is this medicine prescribed?
Moxetumomab pasudotox-tdfk injection is used to treat hairy cell leukemia (cancer of a certain type of white blood cell) that has returned or has not responded after at least two other cancer treatments. Moxetumomab pasudotox-tdfk injection is in a class of medications called monoclonal antibodies. It works by helping your immune system to slow or stop the growth of cancer cells.
HOW should this medicine be used?
Moxetumomab pasudotox-tdfk injection comes as a powder to be mixed with liquid and injected into a vein by a doctor or nurse in a medical office or hospital. It is usually injected slowly over a period of 30 minutes on days 1, 3, and 5 of a 28-day treatment cycle. This cycle may be repeated for up to 6 cycles. The length of treatment depends on how well your body responds to the medication and any side effects you experience.
During your treatment, your doctor will ask you to drink up to twelve 8-oz glasses of liquids such as water, milk or juice every 24 hours on days 1 through 8 of each 28-day treatment cycle.
Moxetumomab may cause serious reactions during or after you receive your infusion. You will be given medications 30 to 90 minutes before your infusion and after your infusion to help prevent reactions to moxetumomab. Your doctor may need to stop your treatment if you experience certain side effects. Tell your doctor if you experience any of the following symptoms: dizziness, fainting, wheezing or difficulty breathing, shortness of breath, fast heartbeat, muscle pain, nausea, vomiting, headache, fever, chills, cough, fainting, hot flashes, or flushing. It is important for you to tell your doctor how you are feeling during your treatment with moxetumomab pasudotox-tdfk injection. Call your doctor right away or get immediate emergency medical attention if you experience any of these symptoms after you leave your doctor's office or medical facility.
Your doctor may reduce your dose, delay or stop your treatment with moxetumomab pasudotox-tdfk injection, or treat you with additional medications depending on your response to the medication and any side effects that you experience. Talk to your doctor about how you are feeling during your treatment.
Are there OTHER USES for this medicine?
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What SPECIAL PRECAUTIONS should I follow?
Before receiving moxetumomab pasudotox-tdfk injection,
What SPECIAL DIETARY instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do IF I FORGET to take a dose?
If you miss an appointment to receive an infusion, call your doctor as soon as possible to reschedule your appointment.
What SIDE EFFECTS can this medicine cause?
Moxetumomab pasudotox-tdfk injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING or HOW sections, call your doctor immediately or get emergency medical treatment:
Moxetumomab pasudotox-tdfk injection may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online ( http://www.fda.gov/Safety/MedWatch ) or by phone (1-800-332-1088).
What OTHER INFORMATION should I know?
Ask your pharmacist any questions you have about moxetumomab pasudotox-tdfk injection.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
AHFS® Consumer Medication Information. © Copyright, The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.
Selected Revisions: November 15, 2018.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.